OnCo
technologiesTechnologyEstablished

Geriatric assessment

Geriatric assessment is a structured check of an older patient's fitness, memory, and support that predicts treatment tolerance better than age.

GAP70+ and GAIN trials showed geriatric-assessment-guided management reduces severe chemotherapy toxicity by roughly 20% without compromising survival. Recommended by ASCO for all patients ≥65 receiving chemotherapy.

Schematic · not to scale
Function, cognition, nutrition, support

How it works

Validated domains (function, comorbidity, cognition, nutrition, social support) inform dose and regimen choice.

Strengths
  • Reduces harm, improves shared decision-making
Limitations
  • Time and uptake

Key papers

1top

Latest papers

top
Literature trend332 papers in the last 12 months+14% vs prior 12How this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"geriatric assessment" OR ABSTRACT:"geriatric assessment") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Geriatric assessment, not a curated reading list.

Connected

51top

Pages like this

not linked directly; found by shared links

fronts

1

technologies

6

institutions

5

pathways

1

terms

6

roadmaps

1

ideas

22
A dedicated programme for cachexia and treatment toxicity researchA defined pathway for patients with both dementia and cancerA dietitian in every gastrointestinal and head and neck tumour boardA fixed share of trial-group funding for getting proven care to patientsA mandatory over-70s cohort with geriatric assessment in every pivotal trialA trials fund reserved for older and multimorbid patientsAn automatic electronic frailty index inside the oncology recordCatch wasting early with a smart scale and a step counterDose-finding in older and frail patients, not extrapolation from fit onesFour weeks of training and nutrition before major cancer surgery, as standardGeriatric assessment by default for every older patient, and trials that admit themGeriatric assessment by default for every patient over 70 starting cancer treatmentGeriatrician co-management for older patients having cancer surgeryHormone tablets instead of surgery for small breast cancers in the frail over-80sMandatory real-world reporting for patients excluded from pivotal trialsOne-two punch: clear senescent cells after chemotherapyParallel real-world cohorts for sicker patients alongside every pivotal trialPragmatic trials in patients over 75 with function, not just survival, as the primary endpointQualify a physical function endpoint so anti-wasting drugs can be approvedRead muscle loss automatically from scans patients already haveStop screening by life expectancy, not birthday, with a tool in the recordTreat wasting like sepsis: a trigger, a bundle, an audit

people

4

bottlenecks

4

key papers

1